
Raybliss Pharma Private Limited
About Raybliss Pharma Private Limited
Data last updated:
Raybliss Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It was incorporated on 01 June 2023.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U46497KA2023PTC174431. Its GSTIN is 29AAMCR7331N1ZM (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raveesh Hanumanthaiah and Ramalingapura Sathyanarayana Aishwarya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.21 Lakh. For the same year it recorded a net profit of ₹8,216 (net margin 0.3%) and EBITDA of ₹3.18 Lakh (EBITDA margin 13.2%).
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Company details
Contact details
Raybliss Pharma Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressNo. 213 2nd Floor, 3rd Block 2nd Stage Nagarbhavi Main Road Nagarbhavi, Bangalore, Karnataka, India – 560072
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Raybliss Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Raybliss Pharma Private Limited, buy the company report.
Financials of Raybliss Pharma Private Limited
FY 2025 filings availableRaybliss Pharma Private Limited reported revenue of ₹24.21 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹3.18 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹8,216 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 13.2% | |
| Net Profit Margin | 0.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Raybliss Pharma Private Limited, buy the company report.
Board of directors of Raybliss Pharma Private Limited
Raybliss Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raveesh Hanumanthaiah | Director | 01 Jun 2023 | 3 Years 5 Months | Current |
| Ramalingapura Sathyanarayana Aishwarya | Additional Director | 01 Jul 2024 | 2 Years 4 Months | Current |
Peer comparison
Raybliss Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amezia Pharmaceutical Private Limited | ₹24.54 Lakh (FY 2025) | 75.0% | Mumbai, Maharashtra, India | |||
| Merit Healthcare Private Limited | ₹24.51 Lakh (FY 2025) | -32.0% | Mumbai, Maharashtra, India | |||
| Sanlee Healthcare Private Limited | ₹24.41 Lakh (FY 2025) | 55.0% | Hyderabad, Telangana, India | |||
| Zealx Pharma Solutions Private Limited | ₹24.36 Lakh (FY 2025) | Karnal, Haryana, India | ||||
| Bonzer Packaging Private Limited | ₹24.33 Lakh (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Raybliss Pharma Private Limitedthis company | ₹24.21 Lakh (FY 2025) | ₹8,216 | 0.3% | Bangalore, Karnataka, India | ||
| Shubhyog Microtechnology Private Limited | ₹24.17 Lakh (FY 2024) | 34.0% | Muzaffarnagar, Uttar Pradesh, India | |||
| Alestra Lifesciences Limited | ₹24 Lakh (FY 2025) | 488.0% | Kolkata, West Bengal, India | |||
| Oram Biochem Private Limited | ₹23.91 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Strelitzia Pharmaceuticals Private Limited | ₹23.87 Lakh (FY 2025) | Ernakulam, Kerala, India | ||||
| Ista Life Care Private Limited | ₹23.81 Lakh (FY 2025) | 124.0% | Sangareddy, Telangana, India |
To see the full peer comparison of Raybliss Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Sep 2023 | 100795694 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Raybliss Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raybliss Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raybliss Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAMCR7331N1ZM | Karnataka | Active | 24 Aug 2023 |
To see the full GST registrations and return filing status of Raybliss Pharma Private Limited, buy the company report.
Recent activity
Raybliss Pharma Private Limited has 3 board changes on record since 2023: 2 appointments and 1 cessation. The latest: Ramalingapura Sathyanarayana Aishwarya was appointed as Additional Director on 01 Jul 2024.
Frequently asked questions
Raybliss Pharma is an active private limited company based in Bangalore, Karnataka, India. It was incorporated on 01 June 2023 (3+ years old) and is registered under CIN U46497KA2023PTC174431.
Raybliss Pharma has 2 current directors:
- Raveesh Hanumanthaiah - Director
- Ramalingapura Sathyanarayana Aishwarya - Additional Director
The latest financial statements of Raybliss Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Raybliss Pharma is 29AAMCR7331N1ZM, registered in Karnataka.
The CIN (Corporate Identification Number) of Raybliss Pharma is U46497KA2023PTC174431. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raybliss Pharma was incorporated on 01 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Raybliss Pharma by revenue are Amezia Pharmaceutical Private Limited, Merit Healthcare Private Limited, Sanlee Healthcare Private Limited, Zealx Pharma Solutions Private Limited, Bonzer Packaging Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Ramalingapura Sathyanarayana Aishwarya was appointed as Additional Director on 01 Jul 2024. Yalachigere Muthahanumaiah Hanumanthaiah ceased to be Director on 01 Jul 2024. Raveesh Hanumanthaiah was appointed as Director on 01 Jun 2023.
The registered office of Raybliss Pharma is at No. 213 2nd Floor, 3rd Block 2nd Stage Nagarbhavi Main Road Nagarbhavi, Bangalore, Karnataka, India – 560072.
Raybliss Pharma has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
Raybliss Pharma can be reached at its registered office: No. 213 2nd Floor, 3rd Block 2nd Stage Nagarbhavi Main Road Nagarbhavi, Bangalore, Karnataka, India – 560072.

